Skip to main content

Penumbra Inc

corporate_fare Company Profile

Penumbra Inc

PEN·NYSE·Life Sciences·CIK 0001321732

Penumbra, Inc. develops, manufactures, and markets medical technologies for challenging conditions like ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. The company specializes in thrombectomy, focusing on removing blood clots from the body using computer assisted vacuum thrombectomy (CAVT). Penumbra's product portfolio also includes technologies for embolization and access. Founded in 2004, Penumbra has introduced products into the thrombectomy market since 2007, the access market since 2008, the embolization market since 2011, and the neurosurgical market since 2014. The company's research and development activities support regulatory submissions and demonstrate product effectiveness. Penumbra aims to provide cost-effective products to specialist physicians and other healthcare providers to improve clinical and health outcomes. When a new generation product is introduced, sales of the older product typically decline.

Penumbra Inc (NYSE:PEN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for PEN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for PEN spans 10-Q, 8-K, 425, DEFM14A.

Recent high-impact activity:

  • Boston Scientific Deal Caps Week as Q3 Revenue Tops Estimates
  • Penumbra Tops $410M Revenue, Up 15.6%, But Suspends Guidance on Boston Scientific Deal
  • FDA Clears Penumbra's Lightning CAVT for Deep Vein Thrombosis, Opening New Market
  • Penumbra Q2 Revenue Beats, but Merger Costs and Tax Normalization Weigh on Earnings
  • Penumbra Tops Q2 Revenue, but Merger Costs and Taxes Erode Net Income

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.4B
Net Income
$177.69M
Diluted EPS
$4.52
Op. Cash Flow
$238.66M
Free Cash Flow
$174.93M
Gross Profit
$942.44M
Operating Income
$189.25M
Cash & Equivalents
$186.9M
Debt / Equity
0.00×
Net Margin
12.7%
Shares Outstanding
39.23M sh
Source: 10-K · filed 2026-02-25 · accession 0001321732-26-000007

Short Interest & Short Volume

5.29 days to cover

FINRA reported short interest of 2,403,093 shares in PEN as of the October 30, 2026 settlement, a 6.2% increase from the prior period — about 5.3 days to cover at its recent average daily volume. On November 20, 2026, 45.0% of PEN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,403,093 shares as of October 30, 2026
Change vs prior period▲ 6.2%
Days to cover5.29 at avg daily volume of 454,028
Daily short volume (FINRA facilities)45.0% of 57,463 shares on November 20, 2026
5-day average short volume57.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with P →
$319.12
52-week range · as of 2026-07-30 $221.26 – $362.41
Market cap
$12.58B
Volume
205.4K (0.6× avg)
3-mo avg 351.2K
Live data · 2026-11-22 09:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PEN - Latest Insights

PEN
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $321.99
Real-time Price: $319.12 info
Change: -$2.87 (-0.89%) info
Market Cap: $12.578B info
PEN
Oct 29, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $321.97
Real-time Price: $319.12 info
Change: -$2.85 (-0.89%) info
Market Cap: $12.578B info
PEN
Oct 20, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $321.73
Real-time Price: $319.12 info
Change: -$2.61 (-0.81%) info
Market Cap: $12.578B info
PEN
Jul 30, 2026, 4:44 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $319.12 info
Change: -$0.710 (-0.22%) info
Market Cap: $12.578B info
PEN
Jul 30, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $319.12 info
Change: -$0.710 (-0.22%) info
Market Cap: $12.578B info
PEN
Jul 30, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $319.12 info
Change: -$0.710 (-0.22%) info
Market Cap: $12.578B info
PEN
Jun 15, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $319.06
Real-time Price: $319.12 info
Change: +$0.060 (+0.02%) info
Market Cap: $12.578B info
PEN
Jun 11, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $318.32
Real-time Price: $319.12 info
Change: +$0.800 (+0.25%) info
Market Cap: $12.578B info
PEN
May 07, 2026, 9:01 AM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $323.86
Real-time Price: $319.12 info
Change: -$4.74 (-1%) info
Market Cap: $12.578B info
PEN
May 07, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $323.86
Real-time Price: $319.12 info
Change: -$4.74 (-1%) info
Market Cap: $12.578B info
PEN
May 06, 2026, 4:49 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $324.19
Real-time Price: $319.12 info
Change: -$5.07 (-2%) info
Market Cap: $12.578B info
PEN
May 06, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $324.19
Real-time Price: $319.12 info
Change: -$5.07 (-2%) info
Market Cap: $12.578B info
PEN
Apr 22, 2026, 5:11 PM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $332.21
Real-time Price: $319.12 info
Change: -$13.09 (-4%) info
Market Cap: $12.578B info
PEN
Apr 01, 2026, 4:53 PM EDT
Filing Type: DEFM14A
Importance Score:
9
Price at Filing: $328.96
Real-time Price: $319.12 info
Change: -$9.84 (-3%) info
Market Cap: $12.578B info
PEN
Mar 03, 2026, 4:57 PM EST
Filing Type: 425
Importance Score:
7
Price at Filing: $340.16
Real-time Price: $319.12 info
Change: -$21.04 (-6%) info
Market Cap: $12.578B info
PEN
Feb 25, 2026, 1:27 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $339.42
Real-time Price: $319.12 info
Change: -$20.30 (-6%) info
Market Cap: $12.578B info
PEN
Feb 25, 2026, 1:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $339.23
Real-time Price: $319.12 info
Change: -$20.11 (-6%) info
Market Cap: $12.578B info
PEN
Jan 20, 2026, 5:18 PM EST
Filing Type: 425
Importance Score:
10
Price at Filing: $355.52
Real-time Price: $319.12 info
Change: -$36.40 (-10%) info
Market Cap: $12.578B info
PEN
Jan 16, 2026, 4:12 PM EST
Filing Type: 425
Importance Score:
10
Price at Filing: $352.77
Real-time Price: $319.12 info
Change: -$33.65 (-10%) info
Market Cap: $12.578B info
PEN
Jan 15, 2026, 5:21 PM EST
Filing Type: 425
Importance Score:
10
Price at Filing: $354.50
Real-time Price: $319.12 info
Change: -$35.38 (-10%) info
Market Cap: $12.578B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets